共 120 条
[1]
Silveira-Moriyama L(2008)The use of smell identification tests in the diagnosis of Parkinson’s disease in Brazil Mov Disord 23 2328-2334
[2]
Carvalho Mde J(2012)Application of odoridentifycation test in Parkinson’s disease in China: a matched case-control study J Neurol Sci 316 47-50
[3]
Katzenschlager R(2015)Fully automated quantification of the Striatal uptake ratio of [(99m)Tc]-TRODAT with SPECTImaging: Evaluation of the diagnostic performance in Parkinson’s disease and the temporal regression of Striatal tracer uptake Biomed Res Int 2015 461625-1238
[4]
Petrie A(2015)The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review EJNM MI Res 5 12-928
[5]
Ranvaud R(2014)Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCANTM) in subjects with clinically uncertain parkinsonian syndromes Alzheimers Res Ther 6 67-2351
[6]
Barbosa ER(2007)Role of DAT-SPECT in the diagnostic work up of Parkinsonism Mov Disord 22 1229-34
[7]
Lees AJ(2015)Olfactory testing in children using objective tools: comparison of Sniffin’ Sticks and University of Pennsylvania Smell Identific ation Test (UPSIT) Otolaryngol Head Neck Surg 44 10-1526
[8]
Chen W(2015)Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson’s disease Parkinsonism Relat Disord 21 923-514
[9]
Chen S(2007)DaTSCAN Clinically Uncertain Parkinsonian Syndromes Study Group. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an openlabel study Mov Disord 22 2346-1746
[10]
Kang WY(2013)EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson’s disease Eur J Neurol 20 16-251